Author

Vrushab Gowda

Lawyer, with focus on public health and the sciences. Nonprofit Executive. Philanthropic Advisor. Adjunct Professor of Bioethics. Graduate of Harvard Law School, Harvard T.H. Chan School of Public Health, and Harvard College.

Government Regulation

September 23, 2020

The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing

A recent executive order aimed at addressing ballooning pharmaceutical expenditures is ambitious in scope, but its impact remains to be seen.

The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing
Data Privacy

September 11, 2020

Telehealth Policy Brought to the Fore in the COVID-19 Pandemic

The COVID-19 pandemic has highlighted the value of telehealth as both a tool of necessity as well as of innovation.

Telehealth Policy Brought to the Fore in the COVID-19 Pandemic

Vrushab Gowda

The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing

The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing

Telehealth Policy Brought to the Fore in the COVID-19 Pandemic

Telehealth Policy Brought to the Fore in the COVID-19 Pandemic